CS logo
small CS logo
Genesis Research LLC

San Diego, California, United States
Research institute in San Diego, California
3444 Kearny Villa Rd Suite 201, San Diego, CA 92123

About Genesis Research LLC


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Dendreon
3
Allergan
2
Foresee Pharmaceuticals Co., Ltd.
2
NeoTract, Inc.
2
Blue Earth Diagnostics
1
GP-Pharm
1
Janssen Research & Development, LLC
1
MDx Health
1
NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.)
1
Targacept Inc.
1
UroGen Pharma Ltd.
1
Total Rows: 12

Clinical Trials at Genesis Research LLC


During the past decade, Genesis Research LLC conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 11 clinical trials were completed, i.e. on average, 157.1% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years22220000000011222200333333000000Started TrialsCompleted Trails2015201620172018201920202021202201234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
The Safety and Effectiveness of UroLift: LIFT Pivotal Study
2011-02-01
2017-07-05
Completed
206
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
2011-01-27
2017-01-17
Completed
1,976
DN24-02 as Adjuvant Therapy in Subjects With High Risk HER2+ Urothelial Carcinoma
2011-06-01
2015-07-01
Terminated
142
Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancer
2011-09-01
2013-11-01
Completed
163
Study Evaluating the Safety, Tolerability, and Efficacy of Dexmecamylamine (TC-5214) for Treatment of Overactive Bladder
2013-05-01
2014-06-01
Completed
1,635
UroLift System TOlerability and ReCovery When Administering Local Anesthesia
2013-04-01
2018-09-04
Completed
51
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
2013-10-28
2017-01-05
Completed
254
Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer
2012-01-01
2017-07-01
Terminated
225

Rows per page:

1–17 of 17

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Genesis Research LLC" #1 sponsor was "Dendreon" with 3 trials, followed by "Allergan" with 2 trials sponsored, "Foresee Pharmaceuticals Co., Ltd." with 2 trials sponsored, "NeoTract, Inc." with 2 trials sponsored and "Blue Earth Diagnostics" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Genesis Research LLC" #1 collaborator was "American College of Radiology" with 1 trials as a collaborator, "IND 2 Results LLC" with 1 trials as a collaborator, "QPS-Qualitix" with 1 trials as a collaborator and "Syne Qua Non Limited" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.
Created with Highcharts 11.1.0Top Leading SponsorsDendreon: 3Dendreon: 3Allergan: 2Allergan: 2ForeseePharmaceuticals Co.,Ltd.: 2ForeseePharmaceuticals Co.,Ltd.: 2NeoTract, Inc.: 2NeoTract, Inc.: 2Blue Earth Diagnostics: 1Blue Earth Diagnostics: 1GP-Pharm: 1GP-Pharm: 1Janssen Research &Development, LLC: 1Janssen Research &Development, LLC: 1MDx Health: 1MDx Health: 1NexMed (U.S.A.), Inc.(subsidiary of ApricusBiosciences, Inc.): 1NexMed (U.S.A.), Inc.(subsidiary of ApricusBiosciences, Inc.): 1Targacept Inc.: 1Targacept Inc.: 1

Created with Highcharts 11.1.0Top CollaboratorsAmerican College ofRadiology: 1American College ofRadiology: 1IND 2 Results LLC: 1IND 2 Results LLC: 1QPS-Qualitix: 1QPS-Qualitix: 1Syne Qua Non Limited: 1Syne Qua Non Limited: 1

Clinical Trials Conditions at Genesis Research LLC


According to Clinical.Site data, the most researched conditions in "Genesis Research LLC" are "Prostate Cancer" (3 trials), "Prostatic Neoplasms" (3 trials), "Benign Prostatic Hyperplasia" (2 trials), "Overactive Bladder" (2 trials) and "Urothelial Carcinoma" (2 trials). Many other conditions were trialed in "Genesis Research LLC" in a lesser frequency.

Clinical Trials Intervention Types at Genesis Research LLC


Most popular intervention types in "Genesis Research LLC" are "Drug" (10 trials), "Biological" (4 trials), "Other" (3 trials), "Device" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "18F-fluciclovine PET CT" (1 trials), "Cetrelimab" (1 trials), "Crossover" (1 trials) and "Cystoscopy" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Genesis Research LLC


The vast majority of trials in "Genesis Research LLC" are 11 trials for "Male" genders, 5 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at Genesis Research LLC


Currently, there are NaN active trials in "Genesis Research LLC". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Genesis Research LLC, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Genesis Research LLC, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 6Phase 2: 6Phase 3: 5Phase 3: 5Not Applicable: 2Not Applicable: 2Phase 1: 1Phase 1: 1Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 10Completed: 10Terminated: 3Terminated: 3Active, not recruiting: 2Active, not recruiting: 2Recruiting: 1Recruiting: 1Unknown status: 1Unknown status: 1